Abstract:Background: Inhibin B appears to change earlier than traditional predictors in ovarian aging. The pattern of inhibin B levels is highest in the early to midfollicular phases followed by a decrease in the late follicular phase. This implies that it is secreted by developing follicles and reflects follicular function and oocyte number.Objective: The aim of this preliminary study was to explore the possibility of using the ratio of serum inhibin B concentrations on cycle day 2 and 7 as a predictor for the outcome of in-vitro fertilization (IVF) procedures.Materials and Methods: The subjects, who underwent their IVF/ICSI treatment from April 2004 to September 2004, were enrolled in this study. Typical long protocol with GnRHa down regulation was employed and blood samples were drawn on the cycle day 2 for baseline hormone assessments and on the cycle day 7, the first visit after the ovulation stimulation.Results: The median values of day2 Inhibin B in pregnant and non-pregnant groups were 113.4 and 172 IU/ml, respectively. The ratios of D7/D2 inhibin B in the pregnant group were all higher than 1 but distributed widely in failed group.Conclusion: Seifer et al. (1997) and Hall et al. (2000) suggested a threshold valve for inhibin B (45 pg/ml and 75 pg/ml, respectively) to predict follicular development and success of pregnancy. However, this cut-off valve could not be defined in our study. Interestingly, the ratio of D7/D2, indicating the increase of inhibin B concentrations, in the pregnant women was higher than 1. In contrast, the valves were showed to be lower than 1 in non-pregnant group. This phenomenon seems consistent with the theory which inhibin B is secreted by developing follicles; i.e. if the increase of inhibin B fails, it might indicate oocyte developing system and the response of ovarian stimulation and outcome of treatment would not be satisfactory. Therefore, the ratio of D7/D2 may help in predicting the poor responder and failure of pregnancy in IVF procedure. However, the threshold valve remains to be determined because of the sample number. Background: Inhibin B appears to change earlier than traditional predictors in ovarian aging. The pattern of inhibin B levels is highest in the early to midfollicular phases followed by a decrease in the late follicular phase. This implies that it is secreted by developing follicles and reflects follicular function and oocyte number. Objective: The aim of this preliminary study was to explore the possibility of using the ratio of serum inhibin B concentrations on cycle day 2 and 7 as a predictor for the outcome of in-vitro fertilization (IVF) procedures. Materials and Methods: The subjects, who underwent their IVF/ICSI treatment from April 2004 to September 2004, were enrolled in this study. Typical long protocol with GnRHa down regulation was employed and blood samples were drawn on the cycle day 2 for baseline hormone assessments and on the cycle day 7, the first visit after the ovulation stimulation. Results: The median values of day2 Inhibin B in pregnant and non-pregnant groups were 113.4 and 172 IU/ml, respectively. The ratios of D7/D2 inhibin B in the pregnant group were all higher than 1 but distributed widely in failed group. Conclusion: Seifer et al. (1997) and Hall et al. (2000) suggested a threshold valve for inhibin B (45 pg/ml and 75 pg/ml, respectively) to predict follicular development and success of pregnancy. However, this cut-off valve could not be defined in our study. Interestingly, the ratio of D7/D2, indicating the increase of inhibin B concentrations, in the pregnant women was higher than 1. In contrast, the valves were showed to be lower than 1 in non-pregnant group. This phenomenon seems consistent with the theory which inhibin B is secreted by developing follicles; i.e. if the increase of inhibin B fails, it might indicate oocyte developing system and the response of ovarian stimulation and outcome of treatment would not be satisfactory. Therefore, the ratio of D7/D2 may help in predicting the poor responder and failure of pregnancy in IVF procedure. However, the threshold valve remains to be determined because of the sample number.

[Dynamic Assay of Serum Inhibin B and Estradiol Concentrations Obtained after Gonadotrophin Therapy As Predictors of Ovarian Response in Vitro Fertilization Cycle].

Dynamic Measurements of Serum Inhibin B and Estradiol: Apredictive Evaluation of Ovarian Response to Gonadotrophin Stimulation in the Early Stage of IVF Treatment

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The relationship between serum delta inhibin B levels and ovarian response in IVF/ICSI cycles

Changes and predictive value of inhibin B and follistain on controlled ovarian stimulation for polycystic ovary syndrome infertility treated

Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study

The Ratio of Day 2 and Day 7 Serum Concentrations of Inhibin B As a Predictor of the Outcome of In-Vitro Fertilization

Clinical analysis on detection of inhibin B in 84 cases with infertility

Association of Basal Serum Testosterone Levels with Ovarian Response and in Vitro Fertilization Outcome

[Impact of High Response of Ovary to Gonadotropin Stimulation on the Outcome of in Vitro Fertilization and Embryo Transfer or Intracytoplasmic Sperm Injection].

Role of monitoring sex hormone in ovarian stimulation cycles

Dynamic Serum Testosterone Concentration May Predict in Vitro Fertilization Yield During Ovarian Stimulation by a Gonadotrophin‐releasing Hormone Agonist Long Protocol in Women with Normal Ovarian Reserve

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

Estradiol change after HCG administration and clinical outcome in IVF long protocol ovulation induction cycle

Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.

Factors Influencing Ovarian Response during In Vitro Fertilization and Embryo Transfer

Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles

The Predication of the Results of in Vitro Fertilization and Embryo Transfer by the Ratio of Basal FSH and LH Level

Evaluation of the predictive value for IVF outcomes of serum estrogen level after down regulation

The predictive value of the serum follicle-stimulating hormone to luteinizing hormone ratio affter putuitary down-regulation in IVF

The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders